Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 7/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | GPR3 | P46089 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | PTAFR | P25105 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28521494 | 0.87 | PTAFR (0.43) | CNR2ALDH1A1TSHRPTAFRKDM4E | |
| SCHEMBL28515991 | 0.84 | KIF11 (0.48) | CYP1A2POLBCYP2C19ALDH1A1TSHR | |
| SCHEMBL18763978 | 0.83 | RXRB (0.38) | MEN1KMT2AALDH1A1KIF11RXRA | |
| SCHEMBL28025517 | 0.77 | CNR1 (0.33) | CNR1CNR2CYP1A2TDP1HTR1A | |
| SCHEMBL28025932 | 0.75 | ALOX5AP (0.30) | — | |
| SCHEMBL28219408 | 0.74 | ALDH1A1 (0.36) | MEN1KMT2AHPGDSMN1; SMN2NPSR1 | |
| SCHEMBL28025943 | 0.73 | KIF11 (0.44) | ALDH1A1KIF11RXRARXRBPTAFR | |
| SCHEMBL5076754 | 0.73 | ALDH1A1 (0.41) | HPGDALDH1A1TDP1 | |
| SCHEMBL28025423 | 0.73 | BRD9 (0.34) | MEN1KMT2ATSHRMAPTHTR1A | |
| SCHEMBL28025959 | 0.73 | PTPRC (0.46) | CNR1CNR2TSHRRXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108137729-B | Catalysts for forming multimodal polymers | 埃克森美孚化学专利公司 | 2021-02-05 | — | — | CN | disclosed |
| EP-3148937-B1 | METALLIC COMPLEX CATALYST AND POLYMERIZATION METHODS EMPLOYING SAME | BRIDGESTONE CORP (JP) | 2019-09-18 | — | — | EP | disclosed |
| US-10017595-B2 | Metallic complex catalyst and polymerization methods employing same | BRIDGESTONE CORPORATION (JP) | 2018-07-10 | — | — | US | disclosed |
| US-20170114171-A1 | Metallic Complex Catalyst And Polymerization Methods Employing Same | BRIDGESTONE CORPORATION (JP) | 2017-04-27 | — | — | US | disclosed |
| EP-3148937-A1 | METALLIC COMPLEX CATALYST AND POLYMERIZATION METHODS EMPLOYING SAME | Bridgestone Corporation (JP) | 2017-04-05 | — | — | EP | disclosed |
| WO-2015183770-A1 | METALLIC COMPLEX CATALYST AND POLYMERIZATION METHODS EMPLOYING SAME | BRIDGESTONE CORPORATION (JP) | 2015-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114171-A1 | Metallic Complex Catalyst And Polymerization Methods Employing Same | C5, C1S, C9 | CNR1 630/4885CNR2 335/4885TACR1 3084/4885 |
| US-10017595-B2 | Metallic complex catalyst and polymerization methods employing same | C5, C1S, C9 | CNR1 630/4885CNR2 335/4885TACR1 3084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.